G6PC1 and type 2 diabetes mellitus: Since G6Pase is a central enzyme of hepatic gluconeogenesis, pharmacological treatments aiming to restore signaling pathways regulating the expression and enzyme activity of G6Pase are regarded as potential treatment solutions for T2D.